1 0

    FDA MedWatch Reports for Duvelisib (Case IDs 24604115 and 24458468)

    FDA MedWatch Reports for Duvelisib (Case IDs 24604115 and 24458468)

    $89.00 USD
    $89.00 USD
    Sale Sold out
    Original Request: 1 Request for MedWatch Report for Product Case ID 24604115 • Suspect Product: Duvelisib • Reaction: Hospitalisation • Female 69 YR • Country of occurrence: Not specified • Manufacturer Control Number: Not specified 2 Request for MedWatch Report for Product Case ID 24458468 • Suspect Product: Obinutuzumab; Doxorubicin; Prednisone; Cisplatin; Rituximab; Vincristin Sulfate; Cytarabine; Dexamethasone; Bendamustine; Cyclophosphamide; Duvelisib • Reaction: Off Label Use;Follicular Lymphoma;Diarrhoea •Male 49 YR • Country of occurrence: Russia etc
    Tags: Pharma, MedWatch, 2025
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details